Greenwood Capital Associates’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-100
Closed -$8K 204
2020
Q3
$8K Buy
+100
New +$7.63K ﹤0.01% 183
2018
Q2
Sell
-36,223
Closed -$2.6M 196
2018
Q1
$2.6M Buy
36,223
+11,560
+47% +$832K 0.63% 71
2017
Q4
$1.86M Buy
24,663
+1,879
+8% +$137K 0.43% 82
2017
Q3
$1.66M Sell
22,784
-808
-3% -$58.2K 0.41% 81
2017
Q2
$1.75M Buy
+23,592
New +$1.75M 0.45% 78

Other funds holding CL

Greenwood Capital Associates's CL Position: Q4 2020 in Review

Greenwood Capital Associates sold out of Colgate-Palmolive (CL) in Q4 2020, closing a stake of 100 shares — an estimated $8K sold.

Greenwood Capital Associates first reported a position in CL in Q2 2017 and held it in 5 quarters. The position peaked at $2.6M in Q1 2018. 1,650 funds tracked by Wall St. Rank hold CL as of Q4 2020.

  • Greenwood Capital Associates reported no remaining Colgate-Palmolive position as of Q4 2020 after selling out during the quarter.
  • Greenwood Capital Associates sold 100 Colgate-Palmolive shares in Q4 2020, an estimated $8K.
  • Greenwood Capital Associates first reported a position in Colgate-Palmolive in Q2 2017 and held it in 5 quarters.
  • Greenwood Capital Associates's Colgate-Palmolive position peaked at $2.6M in Q1 2018.
  • 1,650 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2020.

Based on Greenwood Capital Associates's 13F filing for Q4 2020, filed 9 Feb 2021.